SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

WERNER HAROLD R

(Last)

(First)

(Middle)

C/O HEALTHCARE VENTURES LLC

44 NASSAU STREET

(Street)

PRINCETON

08542

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/15/2003

3. Issuer Name and Ticker or Trading Symbol
ADVANCIS PHARMACEUTICAL CORP [ AVNC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	28,550	D
Common Stock	13,523	I	By Partnership⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Convertible Preferred	⁽²⁾	⁽³⁾	Common Stock	1,741,800	$0	I	By Partnership⁽⁴⁾
Series B Convertible Preferred	⁽²⁾	⁽³⁾	Common Stock	1,654,710	$0	I	By Partnership⁽⁵⁾
Series C Convertible Preferred	⁽²⁾	⁽³⁾	Common Stock	3,254,988	$0	I	By Partnership⁽⁶⁾
Series D Convertible Preferred	⁽²⁾	⁽³⁾	Common Stock	6,358,394	$0	I	By Partnership⁽⁷⁾
Series E Convertible Preferred	⁽²⁾	⁽³⁾	Common Stock	3,758,141	$0	I	By Partnership⁽⁸⁾

Explanation of Responses:

1. Represents shares held by the Werner Family Investment Limited Partnership. The Reporting Person is the General Partner of the Werner Family Investment Limited Partnership and, as such, disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.

2. Immediately exercisable.

3. Each of these shares will automatically convert into 0.5464242 shares of Common Stock of the Issuer on the date of the Closing of the initial public offering of the Issuer's securities.

4. These securities are owned by HealthCare Ventures V, L.P. ("HCVV"). The Reporting Person is a general partner of HealthCare Partners V, L.P., the general partner of HCVV. The Reporting Person disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.

5. 870,900 of these securities are owned by HCVV and 783,810 of these securities are owned by HealthCare Ventures VI, L.P. ("HCVVI") The Reporting Person is a general partner of each of HealthCare Partners V, L.P. ("HCPV") and HealthCare Partners VI, L.P. ("HCPVI"), the general partners of each of HCVV and HCVVI, respectively. The Reporting Person disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.

6. 666,666 of these securities are owned by HCVV and 2,588,322 of these securities are owned by HCVVI. The Reporting Person is a general partner of each of HCPV and HCPVI, the general partners of each of HCVV and HCVVI, respectively. The Reporting Person disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.

7. 2,474,886 of these securities are owned by HCVVand 3,883,508 of these securities are owned by HCVVI. The Reporting Person is a general partner of each of HCPV and HCPVI, the general partners of each of HCVV and HCVVI, respectively. The Reporting Person disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.

8. 888,889 of these securities are owned by HCVV, and 2,869,252 of these securities are owned by HCVVI. The Reporting Person is a general partner of each of HCPV and HCPVI, the general partners of each of HCVV and HCVVI, respectively. The Reporting Person disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.

Remarks:

	Jeffrey Steinberg, Attorney-in-Fact	10/15/2003
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.